17-Mar-2020

March 2020 Shareholder Newsletter

Kazia Therapeutics is pleased to make its March 2020 newsletter available to investors.

02-Mar-2020

Dr James Garner interviewed for Switzer Financial Group’s The CEO Masterclass

Our CEO, Dr James Garner sat down with Peter Switzer to discuss Kazia’s upcoming value-driving milestones in 2020 and the development of lead program, paxalisib, for Switzer Financial Group’s The CEO Masterclass series.